Delivery Order SPE2DB22D3016-SPE2DB26FABA2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Adderall 10 mg tablets (100-count) with a ceiling value of $1,330.12. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and represents a non-set-aside, competitively awarded contract. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100-count) on October 27, 2025, with a ceiling value of $2,451.32 and an ultimate completion date of October 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Adderall 10 mg tablets in quantities of 100, with a ceiling value of $4,431.07 and a firm fixed price structure. The contract is non-competitive and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100-count units) with a contract ceiling value of $3,931.85. This competitively awarded, non-set-aside delivery order was executed on October 27, 2025, with an ultimate completion date of October 28, 2025, and reflects firm fixed pricing. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Adderall 5 mg tablets in quantities of 100 units, with a ceiling value of $1,899.03. The contract, awarded on August 18, 2025, carries a firm fixed price structure with an ultimate completion date of August 19, 2025. This non-set-aside competitive award represents a single delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Adderall 10 mg tablets in quantities of 100 units, with a contract value of $4,431.07 and a completion date of April 23, 2025. This delivery order was issued under a firm fixed-price structure with no set-aside designation, indicating competitive award authority. The contract represents a child delivery order against AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Adderall 5 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract has a firm fixed price ceiling value of $1,266.02 and is scheduled for completion by May 7, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Adderall 5 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,266.02 and an ultimate completion date of September 4, 2025. The contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100-count units) with a contract value of $1,899.03. The award, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Adderall tablets (10mg) under a firm fixed-price contract with a ceiling value of $9,584.53. This non-set-aside award represents a competitively awarded delivery order with an ultimate completion date of July 22, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FABA2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall 10 mg tablets (100-count) on October 31, 2025, with a ceiling value of $2,532.04 and completion date of November 3, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The vendor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements for specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 10/31/25 |